Macular edema
Conditions
Sponsors
Tokyo Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients with macular edema 2. Patients with visual acuity of 40/50 or less and central foveal retinal thickness of 300 micro m or more 3. Patients over 20 years old 4. Patients scheduled to receive anti-VEGF agents and expected to continue for at least 12 months 5. Patients who have not been treated with laser, surgery, or injection at other hospitals 6. Patients who have been informed of the purpose and content of this study and have given their free and voluntary consent. 7. Patients who are able to visit the hospital and undergo examinations during the observation period.
Exclusion criteria
Exclusion criteria: 1. Patients undergoing other ocular surgery or intravitreal injection of various drugs 2. Patients with the following diseases (Patients with active uveitis, patients with iris neovascularization, patients with poorly controlled glaucoma 3. Other patients who are judged to be inappropriate as subjects by the principal investigator or a research associate. 4. Patients who refuse to cooperate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual acuity, central foveal retinal thickness/choroidal thickness, flare, blood flow, sensitivity, vascular density | — |
Countries
Japan
Contacts
Public ContactHidetaka Noma
Tokyo Medical University Ibaraki Medical Center Department of Ophthalmology
Outcome results
None listed